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Introduction
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In recent decades, social networks research has contributed to important gains in knowledge
critical to programs designed to decrease the spread of infectious diseases (i.e. HCV, HIV
and other STIs), to chronic conditions (i.e. tobacco use and obesity) ( Flath et al., 2018;
Maddox et al., 2014; Morris, 2004; Luke & Harris, 2007; Rothenberg et al., 1998; Thomas
W. Valente, Gallaher, & Mouttapa, 2004; Thomas W. Valente & Pitts, 2017; Williams et al.
2019; Wu et al. 2018). The relational data collected through social network analysis (Tubaro,
2014) is particularly important for epidemiological research, mapping how a virus or
infectious diseases spread from one person to another within a particular group (Smith &
Christakis, 2008).

Author Manuscript

Social network studies have been particularly critical in demonstrating how the sharing of
drug injection equipment contributes to HIV risk among people who inject drugs (PWID)
(Gosh et al., 2017; Bogart et al., 2018; Latkin et al., 2018). Other social network studies
have demonstrated that PWID were more likely to share needles and injection equipment
with those users with whom they were strongly socially connected, rather than with mere
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acquaintances or those with whom they had weak connections (De et al., 2007; Rudolph et
al., 2017).
Recently, studies have shown that similar social network dynamics underpin the emergence
of a HCV epidemic among PWID (Hellard et al., 2014; Pilon et al., 2011; Rolls et al., 2013).
Social network analysis has been employed not only to illustrate how individual and
structural factors can contribute to HIV and HCV risk behaviors in this group, but also to
model the evolution of HIV and HCV epidemics among PWID and to formulate evidence
based prevention and treatment strategies (Mateu-Gelabert et al., 2018). One important
contribution of social network health research to behavioral, epidemiological, or qualitative
HIV research is the ability to understand the social pattern of infectious diseases within
impoverished and marginalized communities.

Author Manuscript

In turn, the relational quality of social network research, which is one of its main strengths,
also presents particular ethical challenges. As detailed by Borgatti and Molina (2005),
conducting social network research is different from traditional research, where participants
report on themselves. Instead, participants in network studies report not only on themselves
but also on others, who in turn provide the names of other individuals in their social
network. Thus social network research raises unique privacy, confidentiality, and anonymity
challenges, since there is no clear mechanism for securing the consent of individuals named
by participants. This also presents challenges for Ethics Review Boards (IRBs), since
traditional requirements for informed consent of “named” participants could bring this
scientifically critical type of research to a halt (Klovhdal, 2005).

Author Manuscript

The ethical challenges regarding privacy protections in social networks research continues to
evolve with the emergence of new technologies. Social networks health research involving
social media has prompted renewed concerns about privacy, confidentiality and anonymity
Hibbin et al. 2018; Hokke et al. 2018; Lunnay et al. 2015; Samuel & Buchanan 2020; Sellers
et al. 2020).

Author Manuscript

Researchers and bioethicists tend to interpret privacy and confidentiality by taking into
consideration only their own obligations. However, an account of how study participants
understand privacy and confidentiality or the role these considerations play in their decisionmaking process is lacking. While the research experiences of people who inject drugs have
received some examination (Davidson & Page, 2012; Scott, 2008;), this is to our knowledge
this is the first empirical study documenting how PWID involved in a social network study
understand ethical obligations derived from their participation. By drawing on the
experiences of PWID previously enrolled in a large-scale study of social networks and
HIV/HCV risk in rural Puerto Rico, this paper explores the participants’ perspectives on
privacy and confidentiality. Understanding how vulnerable populations perceive norms
around HIV disclosure within their social network will contribute to the conduct of research
in a way experienced as acceptable for participants. One strength of this study is that its
participants’ views are shaped by their actual experience of having been enrolled in a social
network study. Using qualitative methods involving 40 semi-structured interviews with
active PWID 18 years old and older, we documented participants’ views regarding the
privacy and confidentiality issues raised by their engagement in social network research.
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Methods.
Aims.
Data presented in this paper were from measures embedded in a larger study, in which
participants’ views on research trust and attitudes toward financial compensation were also
examined (Abadie, Brown, & Fisher, 2019; Abadie, Goldenberg, Welch-Lazoritz & Fisher,
2018). This study focuses on how people who inject drugs view confidentiality and
disclosure obligations when individuals within their social network are perceived as
violating community norms. The purpose of this research is to (1) identify community
norms on HIV disclosure in the course of social network studies with people who inject
drugs, (2) motivate ethical deliberation around these issues, and (3) inform best research
ethics practices through consideration of study participant’s values.

Author Manuscript

Participants

Author Manuscript

This study was nested within an ongoing, multi-year NIH/NIDA funded parent project on
Social Networks and HIV/HCV risk in among PWID residing in the localities of Cidra,
Cayey, Aguas Buenas, and Comerio, in rural Puerto Rico. Data collection for the Social
Network study was conducted between April 2015 and April 2017 and included N=360
active PWID 18 ≥ years old. Details about the methodology, including recruitment strategy
and sample composition, have been published elsewhere (Abadie, et al., 2016; Abadie, et al.
2017). To document participants’ views about confidentiality, we conducted semi-structured
interviews (N=40) with a subsample of participants in the Social Network study. This was a
convenience sample, with all the attendant limitations, but the broad inclusion criteria helped
ensure sampling of participants from different sociodemographic backgrounds and substance
abuse profiles. Since people who inject drugs in rural Puerto Rico are overwhelmingly male,
we decided not to include women in our convenience sample. We address the effects of this
selection in the limitation section.

Author Manuscript

We secured approval from two Ethics Review Boards (IRBs) for the present research.
Participants provided written consent prior to enrollment in the study. To protect
confidentiality participants were identified through the same identification and coupon
number assigned for the parent study, which also facilitated linkage of participant data to
data gathered through the parent study (e.g., demographics, HIV/HCV status, polysubstance
and injection drug use, and injection risk behaviors). A Community Advisory Board (CAB)
of eight active PWID who had participated in the parent study was established prior to
commencement of data collection. Input of the CAB was sought in drafting the recruitment,
consent and interview procedures, to ensure their cultural appropriateness and sensitivity to
our study population.
Interview Format
With the permission of participants all semi-structured in-depth interviews were audio-taped
at the research office site in Cidra, a location already familiar to study participants. The first
section of the semi-structured interviews collected demographic data such as age, education,
income, costs of acquiring drugs, frequency of drug use and access to health care. We also
collected data about HIV/HCV status and injection risk behaviors. To explore participants’
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attitudes toward confidentiality as well as their views of disclosure obligations when
somebody in their social network violates social or community norms, we asked them to
respond to a vignette asking participants how the principal investigator of a study should
proceed if he/she learned that a HIV positive participant in his/her study shared injection
materials with other participants in the study. One of the strengths of this vignette is that it
presented a realistic scenario for respondents, since all had previously enrolled in the parent
social network study that had tested them for HIV/HCV and had also gathered data on who
had injected or shared injection equipment with whom.
Data analysis

Author Manuscript

Interviews were transcribed, and all personal identifiers were removed. Codes were
developed to convey the wide array of themes present in the narratives. An audit trail was
maintained to keep track of how and why analytic decisions were made, and a codebook was
developed to describe and define all study codes. These codes were iteratively revised and
regrouped until they eventually represented a set of higher-level axial codes
comprehensively describing participants’ understandings of confidentiality and disclosure
obligations in the context of social network health research.

Results
Demographic Information

Author Manuscript

The sociodemographic profile of participants enrolled in the current study shows that all are
males with a median age of 42.4 years and a median number of 22.5 years spent injecting
drugs. Only one in twenty (5%) were HIV-seropositive; a large majority were HCVseropositive (78%). All participants reported having previously experienced incarceration,
and the majority were unemployed (87.5%). Only half had a high school or greater level of
educational attainment. Approximately half had never been married, and all participants in
our sample self-identified as heterosexuals. Finally, a little more than half injected four times
or more a day (55%), and one-third injected two to three times a day (30%). Few reported
having participated in a research study other than the parent study from which they had been
recruited (7.5%).
Major Themes

Author Manuscript

“This is between you and me.”: Investigator confidentiality obligations—
Participants express strong views about protecting their confidentiality as research subjects.
In contrast to PWID in urban areas where interactions can be more impersonal or even
anonymous, PWID in rural areas have very deep personal, and in some cases even familiar
connections with each other. In this context, confidentiality of HIV and HCV results
becomes paramount since the lack of confidentiality can impact not only an individual, but
everybody that is involved in his or her network, something Flaco Pablito [not his real name.
All names reported in the results are pseudonyms] is very aware of:
“If they tell me that it is confidential, we’ll go everywhere, you know, but if it is not
and it leaks to a third, a fourth, a fifth that might have the opportunity to learn
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things one tells you for example, or the results [of the tests], that is not right. This is
between you and me.”
Confidence that confidentiality would be protected, was not assumed, but was a result of the
participant’s experience sharing their information with investigators.
“I trusted you because you conducted the tests and it didn’t go out there, it stayed

there. If the result was positive, it stayed there, if it was negative, it stayed there, it
didn’t go out there, nobody knew this information. I trusted you because what we
said in the office stayed there, it was confidential. The fact that it was confidential
made me trust your study more.” Miguelito
Despite the fact that most participants have not engaged previously in community health
research, they demonstrated a good understanding of the meanings of confidentiality:
“nobody else knows” the tests results”:

Author Manuscript

“Yes, yes, it was very important [confidentiality] it was an additional layer of

reassurance that you are giving me that [survey responses and test results] are
confidential, nobody else knows them”. Vitin
For some, the understanding of confidentiality was not necessarily shaped by previous
research engagements, but through their experiences navigating the health care system,
where most were very familiar with the Health Insurance Portability and Accountability Act
(HIPAA), protecttions of patient medical information:
“Right now, you go to a hospital and none of them can divulge… [your medical

Author Manuscript

record], they can’t say anything else. That’s HIPAA law, if they divulge anything
then you can sue them, you can do a lot of things. I think that his study is like that
and it gives me peace of mind.” Papo.
“He’s under oath”: Attitudes toward disclosure of HIV status.—To explore the
meanings of confidentiality in this population we provided a dilemma adapted from Fisher
(2011): “A researcher knows that an HIV positive participant in his study is sharing
syringes/works with another participant in the study without disclosing this information to
him/her. Should the investigator tell the other participant or not?”

Author Manuscript

The responses were divided in two distinct camps. One group of participants felt that the
confidentiality was paramount and should not be broken under any circumstances while the
other group felt that the HIV+ participant was placing others at risk and that this fact
justified the elimination of confidentiality. Yet, participants’ reasoning went beyond the yes
or no answer, both groups recognized the complexity of the issue and came up with potential
solutions to the problem or further elaborated their views, illustrating the multiple
dimensions behind disclosure of confidential results that reflected both responsibilities of the
investigator and participants. Miguelito presents a straightforward answer to this question.

The investigator should not intervene. It’s the participant that needs to be upfront and tell the
other: “Look, I have this, I can’t share anything [with you]. You’ve been warned, now if you
want to share that’s on you. The participant that has HIV has to speak clearly, and if he
doesn’t then it is something that both will need to sort out…
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Landi espouses a more restricted view, that of confidentiality being an absolute principle that
should be respected because “that’s the way it should be”: “No, because if it is confidential,

then it’s confidential. The researcher can’t say anything. […] But the researcher should not
intervene, it is confidential, and that’s the way it should be. He can’t tell.”
Papo agrees with the latter view but also understands the predicament the researcher is in—
that, being bound by the confidentiality requirements, he should not disclose information
that might save participants’ lives. The researcher, in his view, is “like a priest” during
confession, who “can’t say nothing because he’s under oath”:
P: If you see that the person is not going to say anything and it’s f..king up the other and the
researcher knowing this… if I were the researcher, I would tell because if not the other will
keep hurting other people.

Author Manuscript

I: But you know that the researcher promised everybody that the test results are confidential.
P: But if you see that the person is not helping. You see that it is hurting, I would break the
promise because I wouldn’t see that he keeps hurting and hurting. Then, this one comes and
fucks one, and then another one and then he keeps going. he’s going to keep hurting others.
The researcher might get into trouble by violating the confidentiality. It is like a priest, you
go and confess and then he can’t say nothing because he’s under oath.
I: You think the researcher is like a priest?
P: Yes, it has to be kept secret.
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On the other hand, another group of participants felt that the confidentiality protections
should be lifted if participants’ health and well-being were at risk. Cesar illustrates this
position, though noting that lifting confidentiality arrangements would be “sad and
regretful”:
On the other hand, another group of participants felt that the confidentiality protections
should be lifted if participants’ health and well-being were at risk. Cesar illustrates this
position, though noting that lifting confidentiality arrangements would be “sad and
regretful”: “Yes. If the person with the condition is not been direct and is exposing
somebody’s else health for the rest of his life. It is confidential, but the person is been
widely imprudent and when you are not taking care of yourself or others, I understand that
the researcher should intervene. It is sad and regretful, and I understand that it is an invasion
of privacy, but the person has been irresponsible.

Author Manuscript

El Viejo also believes that the investigator should break confidentiality to avoid serious
harms and that this intervention is ethically justified because the HIV patient is acting
unethically. Furthermore, since HIV-positive PWID can share drugs safely, there is no reason
not to disclose their status, providing a further justification to break the confidentiality
agreement:
The investigator should approach the exposed participant and tell him: “Look, this guy has
this, just in case he didn’t tell you.” I think that the investigator should tell because he
J Empir Res Hum Res Ethics. Author manuscript; available in PMC 2021 July 06.
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wouldn’t be violating anybody’s right. The person that is in the wrong is the patient that is
sick and wants to kill the other. In some US states it’s a crime if an HIV-positive person
knowingly transmits the disease to another one. The investigator should intervene to save a
life. Let me tell you something, when I was in jail, I saw somebody share injection
equipment with his nephew without telling him that he had AIDS. The nephew was
insisting, insisting, and at the end he says, ‘OK! Get the damn syringe,’ and he gave the
infected needle to his own nephew! If the investigator tells the participant [that the injection
partner is HIV positive] and as a result he kills the other, that’s not the investigator’s fault. It
is because he [the participant] felt used. If the other had disclosed his status, nothing would
have happened. Do you remember Angel? He would tell everybody, and if somebody didn’t
know about his status, he would tell them: “no, I would go first, gave me my dose first and
then you throw away that needle. I have the condition.”

Author Manuscript

Luis initially agrees with the notion that the researcher should disclose the HIV status of a
study participant, but when reminded of the researcher’s obligation to maintain
confidentiality he advances a creative solution to the problem that enables the researcher to
maintain confidentiality obligations while also safeguarding the well-being of study
participants:
I. Should the researcher disclose the HIV status? Why?
Luis. Yes. To save a life.
I. But keep in mind that the researcher tells everybody that results are confidential.

Author Manuscript

Luis. Confidential. Well, then the best would be that you call the person that has an HIVpositive result and tell him, with all due respect, you know that this is confidential, you know
that your test result is positive, if you are going to do a “caballo” sharing drugs with others,
why don’t you tell him the truth, that you have “la condicion,” HIV, so he can take care?
Instead of the researcher telling the other person, he has a conversation with whoever tested
positive. It stays confidential.
I. And if you were the person that is sharing drugs with the participant that tested HIV
positive and the researcher does not tell you anything, how would this make feel?
L. I wouldn’t change my view of him because when one enters here the first thing that one is
told is that everything is confidential. And you can’t divulge the lives of others.

Discussion
Author Manuscript

The narratives of PWIDs in this study demonstrate that participants value and expect
investigators to honor obligations of privacy and confidentiality as a requirement for their
enrollment in social network health research. Participants worry that confidential HIV tests
results might become known by others in their social network or those in the community at
large. Disclosure of HIV status or other confidential information within a tight social
network can have serious consequences, from reinforcing stigmatization, to retaliatory
violence (Conroy & Wong, 2015; Hammett et al., 2015; Yonah, Fredrick, & Leyna, 2014).
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Yet as participants’ responses to the vignette illustrates, people who inject drugs approach
ethical dilemmas faced by investigators through their own moral lens suggesting that privacy
and confidentiality requirements might be waived if community norms have been violated or
in order to protect the health and well-being of their members. As Luis’s response shows,
study participants can adopt a pragmatic approach, taking contextual factors into
consideration to produce a creative solution that simultaneously allows the researcher to
maintain confidentiality obligations while also reducing the risk of HIV transmission and
associated harms. This ability for moral lens should not be surprising; other studies confirm
that lay members and, in particular, economically marginalized people who use drugs can
engage in complex ethical deliberations (Fisher, et al., 2009; Fisher, 2011).

Author Manuscript
Author Manuscript
Author Manuscript

The empirical examination of privacy and confidentiality issues arising from social network
research among people who inject drugs can be framed within a goodness-of-fit ethical
framework (GFE) that conceptualizes participant protections in terms of the extent to which
ethical procedures are fitted to the needs of the participant population (Fisher, 2015; Fisher
& Goodman, 2009). The GFE’s conceptualization of confidentiality risks shifts judgments
regarding ethical procedures away from an exclusive focus on the privacy vulnerabilities
faced by PWID in their daily life and toward the implementation of specific ethical practices
that minimize privacy risks, maximize privacy protections, and best advance science to
inform population-sensitive interventions. This approach also suggests that researchers and
bioethicists need to consider not only researcher obligations toward participants but,
critically, the ways that study participants perceive confidentiality and privacy obligations.
Failure to do so might be perceived as violating important community norms, resulting in a
potential lack of trust. People who inject drugs expect that the researcher in the study will
preserve their privacy and confidentiality unless there is an overwhelming reason to break
this obligation. Yet, as studies on research trust have shown, trust building is not an event,
like the signing of the consent form, but a social process in which both researcher and
subject become aware of each other goals and can share some kind of common good. As
research on trust has shown, research participants perceive trust as part of a reciprocal
relationship, where both participants and researchers help each other in the pursuit of their
particular goals (Collins et al., 2017; Guillemin et al., 2016; Morgan, Lee, & Sebar, 2015;
Abadie, Shira Goldenberg, Melissa Welch-Lazoritz, & Fisher. 2018; Zamudio-Haas,
Mahenge, Saleem, Mbwambo, & Lambdin, 2016, Reed, Fisher, Blankenship, West, &
Khoshnood, 2017). In this context, research participants might support limiting privacy to
preserve community norms or avoid larger harms. This is particularly important in social
network studies which might require to identify not only participants’ names or identifiable
information, but also non-anonymized data of alters in the social network. During HIV
testing for the Social Network and HIV/HCV risk study, we conducted hundreds of tests,
with an HIV prevalence close to 5%. Frequently we knew all the participants who had
shared injection equipment with the HIV-positive participant. While maintaining
participants’ confidentiality, our staff provided the standard safe injection recommendations
but in addition suggested that HIV-positive participants refrain from sharing if possible. If
avoiding sharing injection equipment was not feasible, participants were advised to disclose
their HIV status to their partners if they had not done so already. This approach, which is
very similar to one suggested by one of our participants, preserved our obligation toward
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maintaining participants’ privacy and confidentiality while also minimizing community
harms.
By documenting how PWID understand privacy and confidentiality in the context of social
network research, this study contributes to larger debates about research ethics with
marginalized populations. Findings suggest that participants understand that some
constraints may exist regarding the protection of privacy and confidentiality in social
network research but that they are willing to participate if trust in the researchers is present,
if the study is perceived to contribute to the social good, and if it does not oppose
community norms.

Limitations
Author Manuscript
Author Manuscript

While one of the strengths of this study is that participants’ views on privacy are based on
their previous engagement in a large study of social networks and risk in Puerto Rico, we
acknowledge that the sample size, while standard for qualitative inquiry, might produce
more robust results were it larger and randomly selected. Another limitation is that, given the
convenience sampling strategy employed, results cannot be generalized beyond this
population. The fact that this study has not collected data about how women who inject
drugs understand privacy in the context of the social network is another limitation. Our
sample composition is entirely male; this choice reflects not only the demographic
background in our parent study but also a more general distribution among PWID, who tend
to be extremely gendered, with many more men than women choosing intravenous drug use,
at least in the US and Western countries. This study only enrolled PWID that had
participated in the parent study. It is possible that this selection could have introduced some
selection bias: those prospective participants with serious privacy concerns might have
refused to enroll in the parent study, and, therefore, their views would not have been taken
into consideration in this study. It is possible that this bias might have eliminated more
extreme privacy views in our sample. Finally, this study assumed that conducting social
network studies with this vulnerable population was desirable, but it did not ask participants
if they agreed with that assessment—for example, if they considered that the benefits of the
study outweighed the risks. Finally, this study shows complex moral reasoning on privacy
and consent among its participants, but it is possible that they might have benefited from the
fact that they were responding not to hypothetical situations but from their actual
experiences as research subjects.

Best Practices
Author Manuscript

Results show that people who inject drugs value and expect privacy and confidentiality in
the course of social network studies research but might be willing to see investigators lift
certain privacy rights in certain circumstances. Researchers and study participants might
harbor different expectations around the perceived obligations related to the disclosure of
HIV test results. To avoid conflicts or misunderstandings, confidentiality expectations about
HIV/HCV test results should be clearly addressed during the consent process. Participants
should be informed of the procedures adopted to maintain the privacy and confidentiality of
medically sensitive information. The potential for conflicting perceived obligations between
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the researchers’ duty to maintain confidentiality and participants’ expectations that privacy
might be lifted to protect participant well-being in accordance with community norms
should be addressed. While social network studies involving people who inject drugs are a
small fraction of all epidemiological and community-based studies conducting HIV testing
with vulnerable populations, researchers in these fields should be mindful of community
norms around HIV disclosure. Clear communication of expectations about this issue is
critical to secure and maintain research trust.

Research Agenda

Author Manuscript

Our findings, which are based on a sample primarily of men who inject drugs in poor, rural
settings in Puerto Rico, might not be generalizable to other populations. While some
concerns about privacy and confidentiality in social network studies might be shared by
PWID in urban settings, or by users from different ethnic backgrounds, or in a different
gender composition where women are more prevalent, more research is needed to document
such continuities and changes. In addition, while this study focuses on the particular ethical
issues raised by social network studies among PWID, the question of whether other
vulnerable populations enrolled in similar studies might share the same concerns, requires
further attention.

Educational Implications

Author Manuscript

Research findings suggest that researchers conducting social network studies, those involved
in community-based research with people who inject drugs, and IRBs need to be aware of
study participants’ views around privacy and confidentiality. Engaging participants in
dialogue about the responsible conduct of research presents an opportunity to correct underor overestimations of research vulnerabilities when such decisions are restricted to the
perspectives of investigators or IRB members (Fisher, 1999).
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